Murray Stahl's BEAM Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 9,597 shares of Beam Therapeutics Inc. (BEAM) worth $232,919, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Murray Stahl has maintained a strategic position in BEAM, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 403 shares. Largest reduction occurred in Q4 2023, reducing 403 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Beam Therapeutics (BEAM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beam Therapeutics (BEAM) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +10,000 | New Buy | 10,000 | $30.62 |
| Q4 2023 | -403 | Reduce 4.03% | 9,597 | $27.22 |
| Q3 2024 | -403 | Reduce 4.20% | 9,194 | $24.50 |
| Q4 2024 | +403 | Add 4.38% | 9,597 | $24.80 |
| Q1 2025 | -9,597 | Sold Out | 9,597 | $0.00 |
| Q3 2025 | +9,597 | New Buy | 9,597 | $24.27 |
Murray Stahl's Beam Therapeutics Investment FAQs
Murray Stahl first purchased Beam Therapeutics Inc. (BEAM) in Q1 2023, acquiring 10,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Beam Therapeutics Inc. (BEAM) for 11 quarters since Q1 2023.
Murray Stahl's largest addition to Beam Therapeutics Inc. (BEAM) was in Q1 2023, adding 10,000 shares worth $306,200.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 9,597 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $232,919.
As of the Q3 2025 filing, Beam Therapeutics Inc. (BEAM) represents approximately 0.00% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Beam Therapeutics Inc. (BEAM) was 10,000 shares, as reported at the end of Q1 2023.